Harbour Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
3,824
+398
+12% +$148K 0.02% 654
2026
Q1
$1M Buy
3,426
+607
+22% +$199K 0.02% 761
2025
Q4
$988K Buy
2,819
+1,140
+68% +$385K 0.02% 614
2025
Q3
$542K Buy
1,679
+2
+0.1% +$622 0.01% 794
2025
Q2
$652K Sell
1,677
-62
-4% -$24.9K 0.02% 676
2025
Q1
$756K Sell
1,739
-149
-8% -$59.8K 0.02% 576
2024
Q4
$696K Sell
1,888
-169
-8% -$70.7K 0.02% 591
2024
Q3
$1.07M Sell
2,057
-32
-2% -$17.1K 0.03% 433
2024
Q2
$1.13M Buy
2,089
+822
+65% +$434K 0.04% 390
2024
Q1
$657K Buy
1,267
+32
+3% +$15.9K 0.02% 504
2023
Q4
$582K Buy
1,235
+30
+2% +$13.9K 0.02% 495
2023
Q3
$525K Sell
1,205
-138
-10% -$62.6K 0.03% 475
2023
Q2
$597K Buy
1,343
+172
+15% +$79.3K 0.03% 453
2023
Q1
$538K Buy
1,171
+312
+36% +$148K 0.03% 453
2022
Q4
$441K Buy
859
+115
+15% +$58.4K 0.03% 485
2022
Q3
$359K Hold
744
0.02% 500
2022
Q2
$359K Buy
+744
New +$368K 0.02% 500
2021
Q4
$352K Sell
759
-964
-56% -$406K 0.02% 521
2021
Q3
$642K Sell
1,723
-15
-0.9% -$5.7K 0.02% 560
2021
Q2
$664K Buy
1,738
+48
+3% +$18.3K 0.02% 564
2021
Q1
$607K Buy
+1,690
New +$543K 0.02% 532

Other funds holding ELV

Harbour Investments's ELV Position: Q2 2026 in Review

Harbour Investments increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $148K and bringing the position to 3,824 shares worth $1.48M. The position accounts for 0.02% of the portfolio, ranked #654.

Harbour Investments first reported a position in ELV in Q1 2021 and has held it in 21 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Harbour Investments held 3,824 shares of Elevance Health worth $1.48M as of Q2 2026.
  • Harbour Investments bought 398 Elevance Health shares in Q2 2026, an estimated $148K.
  • Elevance Health made up 0.02% of Harbour Investments's portfolio in Q2 2026, its #654 holding.
  • Harbour Investments first reported a position in Elevance Health in Q1 2021 and has held it in 21 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.